TAKARA HOLDINGS INC.

NEWS RELEASE

This page introduces the press release provided to journalists.

2008

page top

2008.12.01

Supply of RetroNectin^® to UCLA for TCR-gene therapy clinical trials of advanced melanoma

2008.10.07

Start of the HSV-TK Gene Therapy Clinical Trial for Relapsed Leukemia

2008.09.29

Takara Bio Inc. to supply RetroNectin^® to University of Washington School of Medicine for gene therapy targeting glioblastoma, a type of malignant brain tumors

2008.09.10

Takara Bio Grants Promega Corporation a license for LA-PCR Technology

2008.09.01

Takara Bio to collaborate with Sun Yat-Sen University in China to conduct clinical research of cancer immunotherapy targeting hepatocellular carcinoma using RetroNectin^® expansion culture system

2008.06.03

Takara Bio has established an endowed chair in Kyoto Prefectural University of Medicine for clinical development on cutting edge cancer immunotherapy

2008.05.13

Announcement of Takara Bio's mid-term management plan

2008.04.30

Start of clinical research of cancer immunotherapy using RetroNectin^® expansion culture system at Tianjin Cancer Institute & Hospital, China

page top